Published in Ann Biomed Eng on July 01, 2004
Engineering complex tissues. Tissue Eng (2006) 2.53
Craniofacial tissue engineering by stem cells. J Dent Res (2006) 2.48
Engineering anatomically shaped human bone grafts. Proc Natl Acad Sci U S A (2009) 2.37
CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model. J Clin Invest (2010) 1.97
Mesenchymal stem cells and tissue engineering. Methods Enzymol (2006) 1.71
Injectable biomaterials for regenerating complex craniofacial tissues. Adv Mater (2009) 1.60
Engineering orthopedic tissue interfaces. Tissue Eng Part B Rev (2009) 1.45
Continuing differentiation of human mesenchymal stem cells and induced chondrogenic and osteogenic lineages in electrospun PLGA nanofiber scaffold. Biomaterials (2006) 1.41
Biomimetic approach to tissue engineering. Semin Cell Dev Biol (2008) 1.30
Labeling of mesenchymal stem cells by bioconjugated quantum dots. Nano Lett (2007) 1.28
Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues. PLoS One (2008) 1.26
Engineering custom-designed osteochondral tissue grafts. Trends Biotechnol (2008) 1.25
Biomaterials approach to expand and direct differentiation of stem cells. Mol Ther (2007) 1.24
Sustained release of TGFbeta3 from PLGA microspheres and its effect on early osteogenic differentiation of human mesenchymal stem cells. Tissue Eng (2006) 1.19
Shear stress induces osteogenic differentiation of human mesenchymal stem cells. Regen Med (2010) 1.17
Tissue formation and vascularization in anatomically shaped human joint condyle ectopically in vivo. Tissue Eng Part A (2009) 1.15
Screening for 3D environments that support human mesenchymal stem cell viability using hydrogel arrays. Tissue Eng Part A (2009) 1.12
Inhibition of osteogenic differentiation of human mesenchymal stem cells. Wound Repair Regen (2007) 1.11
Temporomandibular disorders: a review of etiology, clinical management, and tissue engineering strategies. Int J Oral Maxillofac Implants (2013) 1.11
Biofabrication of osteochondral tissue equivalents by printing topologically defined, cell-laden hydrogel scaffolds. Tissue Eng Part C Methods (2011) 1.10
Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering. Adv Drug Deliv Rev (2007) 1.10
Spatial regulation of human mesenchymal stem cell differentiation in engineered osteochondral constructs: effects of pre-differentiation, soluble factors and medium perfusion. Osteoarthritis Cartilage (2010) 1.09
Osteochondral tissue engineering: scaffolds, stem cells and applications. J Cell Mol Med (2012) 1.08
Adipose tissue engineering from human adult stem cells: clinical implications in plastic and reconstructive surgery. Plast Reconstr Surg (2007) 1.06
Successful periodontal ligament regeneration by periodontal progenitor preseeding on natural tooth root surfaces. Stem Cells Dev (2011) 1.06
Effects of chondrogenic and osteogenic regulatory factors on composite constructs grown using human mesenchymal stem cells, silk scaffolds and bioreactors. J R Soc Interface (2008) 1.01
Modulation of endochondral development of the distal femoral condyle by mechanical loading. J Orthop Res (2006) 0.98
Osteochondral interface regeneration of rabbit mandibular condyle with bioactive signal gradients. J Oral Maxillofac Surg (2011) 0.97
Chondrogenesis by chemotactic homing of synovium, bone marrow, and adipose stem cells in vitro. FASEB J (2011) 0.96
Sustained inflammation induces degeneration of the temporomandibular joint. J Dent Res (2012) 0.94
Autologous stem cell regeneration in craniosynostosis. Bone (2007) 0.91
Three-dimensional printed multiphase scaffolds for regeneration of periodontium complex. Tissue Eng Part A (2014) 0.90
Shape, loading, and motion in the bioengineering design, fabrication, and testing of personalized synovial joints. J Biomech (2009) 0.90
Engineering cartilage and bone using human mesenchymal stem cells. J Orthop Sci (2007) 0.89
Informing future cartilage repair strategies: a comparative study of three different human cell types for cartilage tissue engineering. Cell Tissue Res (2013) 0.84
Human umbilical cord mesenchymal stromal cells in a sandwich approach for osteochondral tissue engineering. J Tissue Eng Regen Med (2010) 0.81
Physicochemical control of adult stem cell differentiation: shedding light on potential molecular mechanisms. J Biomed Biotechnol (2010) 0.80
Competitive stem cell recruitment by multiple cytotactic cues. Lab Chip (2013) 0.80
Stem cell therapy in oral and maxillofacial region: An overview. J Oral Maxillofac Pathol (2012) 0.79
Modulation of neonatal growth plate development by ex vivo intermittent mechanical stress. J Biomech (2007) 0.78
Tissue Engineering Whole Bones Through Endochondral Ossification: Regenerating the Distal Phalanx. Biores Open Access (2015) 0.77
Modeling and Validation of Multilayer Poly(Lactide-Co-Glycolide) Scaffolds for In Vitro Directed Differentiation of Juxtaposed Cartilage and Bone. Tissue Eng Part A (2015) 0.76
A biphasic scaffold based on silk and bioactive ceramic with stratified properties for osteochondral tissue regeneration. J Mater Chem B Mater Biol Med (2015) 0.75
Reforming craniofacial orthodontics via stem cells. J Int Soc Prev Community Dent (2015) 0.75
Recent Tissue Engineering Advances for the Treatment of Temporomandibular Joint Disorders. Curr Osteoporos Rep (2016) 0.75
A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med (2004) 4.37
The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med (2013) 4.32
In search of the in vivo identity of mesenchymal stem cells. Stem Cells (2008) 4.17
miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer (2008) 4.09
Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev (2009) 3.73
Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol (2011) 3.65
Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study. Lancet (2010) 3.26
Multifunctional chondroitin sulphate for cartilage tissue-biomaterial integration. Nat Mater (2007) 2.92
Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med (2013) 2.60
Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev (2004) 2.60
Variable cytocompatibility of six cell lines with photoinitiators used for polymerizing hydrogels and cell encapsulation. Biomaterials (2005) 2.44
FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol (2005) 2.31
A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nat Med (2009) 2.31
The effect of incorporating RGD adhesive peptide in polyethylene glycol diacrylate hydrogel on osteogenesis of bone marrow stromal cells. Biomaterials (2005) 2.20
CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model. J Clin Invest (2010) 1.97
The STRO-1+ marrow cell population is multipotential. Cells Tissues Organs (2002) 1.95
Human cartilage repair with a photoreactive adhesive-hydrogel composite. Sci Transl Med (2013) 1.87
Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models. Nat Neurosci (2012) 1.86
Isolation and characterization of a population of immature dental pulp stem cells expressing OCT-4 and other embryonic stem cell markers. Cells Tissues Organs (2006) 1.82
Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials (2007) 1.78
Mesenchymal stem cells and tissue engineering. Methods Enzymol (2006) 1.71
Effects of initial seeding density and fluid perfusion rate on formation of tissue-engineered bone. Tissue Eng Part A (2008) 1.70
Peripheral blood monocytes from patients with HBV related decompensated liver cirrhosis can differentiate into functional hepatocytes. Am J Hematol (2007) 1.66
In situ forming degradable networks and their application in tissue engineering and drug delivery. J Control Release (2002) 1.61
Isolation of human marrow-derived mesenchymal stem cells. Exp Hematol (2006) 1.60
Immunochemical and mechanical characterization of cartilage subtypes in rabbit. J Histochem Cytochem (2002) 1.56
Fibroblast heterogeneity: more than skin deep. J Cell Sci (2004) 1.55
Cytoskeletal changes of mesenchymal stem cells during differentiation. ASAIO J (2007) 1.55
Reversal of multidrug resistance of gastric cancer cells by downregulation of TSG101 with TSG101siRNA. Cancer Biol Ther (2004) 1.51
Engineering structurally organized cartilage and bone tissues. Ann Biomed Eng (2004) 1.50
Tissue-engineered osteochondral constructs in the shape of an articular condyle. J Bone Joint Surg Am (2005) 1.48
Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol Lung Cell Mol Physiol (2010) 1.46
Optimizing mesenchymal stem cell-based therapeutics. Curr Opin Biotechnol (2009) 1.46
Chondrogenesis of adult stem cells from adipose tissue and bone marrow: induction by growth factors and cartilage-derived matrix. Tissue Eng Part A (2010) 1.45
Overexpression of ZNRD1 promotes multidrug-resistant phenotype of gastric cancer cells through upregulation of P-glycoprotein. Cancer Biol Ther (2004) 1.44
Continuing differentiation of human mesenchymal stem cells and induced chondrogenic and osteogenic lineages in electrospun PLGA nanofiber scaffold. Biomaterials (2006) 1.41
Helicobacter pylori infection may improve the survival of patients with carcinomas. Med Hypotheses (2007) 1.40
Up-regulation of tumor suppressor genes might promote the malignant phenotype of cancer cells. Med Hypotheses (2007) 1.39
Designing zonal organization into tissue-engineered cartilage. Tissue Eng (2007) 1.38
Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells. Tissue Eng Part A (2010) 1.38
Collagen mimetic peptide-conjugated photopolymerizable PEG hydrogel. Biomaterials (2006) 1.38
Mesenchymal stem cells in tissue repair. Front Immunol (2013) 1.35
Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Dig Dis Sci (2009) 1.30
MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation. Stem Cells Int (2013) 1.30
Isolation of rat marrow-derived mesenchymal stem cells. Exp Hematol (2006) 1.29
Topical delivery of mesenchymal stem cells and their function in wounds. Stem Cell Res Ther (2010) 1.28
Labeling of mesenchymal stem cells by bioconjugated quantum dots. Nano Lett (2007) 1.28
Fibroblasts-a diverse population at the center of it all. Int Rev Cell Mol Biol (2009) 1.27
Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues. PLoS One (2008) 1.26
Engineered adipose tissue from human mesenchymal stem cells maintains predefined shape and dimension: implications in soft tissue augmentation and reconstruction. Tissue Eng (2005) 1.23
Influence of adult mesenchymal stem cells on in vitro vascular formation. Tissue Eng Part A (2009) 1.22
MSC frequency correlates with blood vessel density in equine adipose tissue. Tissue Eng Part A (2009) 1.21
Stem cell-based composite tissue constructs for regenerative medicine. Biotechnol Bioeng (2005) 1.21
Photocrosslinkable polysaccharides based on chondroitin sulfate. J Biomed Mater Res A (2004) 1.20
Treatment of osteochondral defects with autologous bone marrow in a hyaluronan-based delivery vehicle. Tissue Eng (2002) 1.20
Sustained release of TGFbeta3 from PLGA microspheres and its effect on early osteogenic differentiation of human mesenchymal stem cells. Tissue Eng (2006) 1.19
Cartilage tissue engineering for laryngotracheal reconstruction: comparison of chondrocytes from three anatomic locations in the rabbit. Tissue Eng (2007) 1.19
Effect of dual growth factor delivery on chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in injectable hydrogel composites. J Biomed Mater Res A (2009) 1.18
Regeneration of dental-pulp-like tissue by chemotaxis-induced cell homing. Tissue Eng Part A (2010) 1.18
Effect of swelling ratio of injectable hydrogel composites on chondrogenic differentiation of encapsulated rabbit marrow mesenchymal stem cells in vitro. Biomacromolecules (2009) 1.18
Clones of ectopic stem cells in the regeneration of muscle defects in vivo. PLoS One (2010) 1.17
Shear stress induces osteogenic differentiation of human mesenchymal stem cells. Regen Med (2010) 1.17
Bioreactors mediate the effectiveness of tissue engineering scaffolds. FASEB J (2002) 1.15
Tissue formation and vascularization in anatomically shaped human joint condyle ectopically in vivo. Tissue Eng Part A (2009) 1.15
Targeted delivery of progenitor cells for cartilage repair. J Orthop Res (2004) 1.15
Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer. Mol Cancer Res (2007) 1.14
Synthesis and characterization of a novel degradable phosphate-containing hydrogel. Biomaterials (2003) 1.13
3D CT angiography of abdominal wall vascular perforators to plan DIEAP flaps. Microsurgery (2007) 1.13
Bioinspired nanofibers support chondrogenesis for articular cartilage repair. Proc Natl Acad Sci U S A (2012) 1.12
Inhibition of osteogenic differentiation of human mesenchymal stem cells. Wound Repair Regen (2007) 1.11
Repair of osteochondral defects with hyaluronan- and polyester-based scaffolds. Osteoarthritis Cartilage (2005) 1.11
Heterogeneous nanostructural and nanoelastic properties of pericellular and interterritorial matrices of chondrocytes by atomic force microscopy. J Struct Biol (2004) 1.10
Suture growth modulated by the oscillatory component of micromechanical strain. J Bone Miner Res (2003) 1.10
Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering. Adv Drug Deliv Rev (2007) 1.10
Enhanced chondrogenesis of mesenchymal stem cells in collagen mimetic peptide-mediated microenvironment. Tissue Eng Part A (2008) 1.10
The enhancement of bone regeneration by gene activated matrix encoding for platelet derived growth factor. Biomaterials (2013) 1.10
In vitro evaluation of macroporous hydrogels to facilitate stem cell infiltration, growth, and mineralization. Tissue Eng Part A (2009) 1.09
Repair of osteochondral defect with tissue-engineered two-phase composite material of injectable calcium phosphate and hyaluronan sponge. Tissue Eng (2002) 1.09
Hyaluronan-based polymer scaffold modulates the expression of inflammatory and degradative factors in mesenchymal stem cells: Involvement of Cd44 and Cd54. J Cell Physiol (2006) 1.09
Effect of large incisor retraction on upper airway morphology in adult bimaxillary protrusion patients. Angle Orthod (2012) 1.09
Bioresponsive phosphoester hydrogels for bone tissue engineering. Tissue Eng (2005) 1.09
Prognostic factors in sinonasal tumors involving the anterior skull base. Head Neck (2004) 1.08
Comparison of osteogenic potentials of visceral and subcutaneous adipose-derived cells of rabbits. Plast Reconstr Surg (2006) 1.08